The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)

Conditions: Coronary Artery Disease Interventions: Drug: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor Sponsors: Clinical Research Centre, Malaysia; University of Malaya; Ministry of Health, Malaysia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials